Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calzetta

Showing results (161-170 of 459) with videos related to

Pageof 46
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|November 4, 2024
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic ReviewPaola Rogliani, Gian Marco Manzetti, Shima Gholamalishahi, et al.
Expert Opinion on Pharmacotherapy|August 19, 2020
Advances with glucocorticoids in the treatment of asthma: state of the artJosuel Ora, Luigino Calzetta, Maria Gabriella Matera, et al.
Journal of Investigational Allergology & Clinical Immunology|December 12, 2019
Why Are Allergens Not Detected in the Bronchoalveolar Lavage Fluid of Patients Undergoing Fiberoptic Bronchoscopy? Possible ExplanationsG Liccardi, L Calzetta, M Milanese, et al.
Expert Opinion on Pharmacotherapy|November 2, 2020
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert reviewBeatrice Ludovica Ritondo, Ermanno Puxeddu, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2026
Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implicationsMaria Gabriella Matera, Clive Page, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 28, 2023
Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Drugs|February 19, 2026
Mucus as a Treatable Trait in Chronic Airway DiseasesMario Cazzola, Paola Rogliani, Josuel Ora, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesisPaola Rogliani, Maria Gabriella Matera, Josuel Ora, et al.
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Review of Respiratory Medicine|November 13, 2020
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?Paola Rogliani, Davide Lauro, Nicola Di Daniele, et al.
Pageof 46

Showing results (161-170 of 459) with videos related to

Sort By:
Pageof 46
International Journal of Chronic Obstructive Pulmonary Disease|November 4, 2024
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic ReviewPaola Rogliani, Gian Marco Manzetti, Shima Gholamalishahi, et al.
Expert Opinion on Pharmacotherapy|August 19, 2020
Advances with glucocorticoids in the treatment of asthma: state of the artJosuel Ora, Luigino Calzetta, Maria Gabriella Matera, et al.
Journal of Investigational Allergology & Clinical Immunology|December 12, 2019
Why Are Allergens Not Detected in the Bronchoalveolar Lavage Fluid of Patients Undergoing Fiberoptic Bronchoscopy? Possible ExplanationsG Liccardi, L Calzetta, M Milanese, et al.
Expert Opinion on Pharmacotherapy|November 2, 2020
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert reviewBeatrice Ludovica Ritondo, Ermanno Puxeddu, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2026
Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implicationsMaria Gabriella Matera, Clive Page, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 28, 2023
Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Drugs|February 19, 2026
Mucus as a Treatable Trait in Chronic Airway DiseasesMario Cazzola, Paola Rogliani, Josuel Ora, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesisPaola Rogliani, Maria Gabriella Matera, Josuel Ora, et al.
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Review of Respiratory Medicine|November 13, 2020
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?Paola Rogliani, Davide Lauro, Nicola Di Daniele, et al.
Pageof 46